Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Change in Account Payables (2021 - 2025)

Core Scientific (CORZW) has disclosed Change in Account Payables for 5 consecutive years, with $28.4 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 4593.67% to $28.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.8 million through Dec 2025, up 187.86% year-over-year, with the annual reading at $10.8 million for FY2025, 187.86% up from the prior year.
  • Change in Account Payables hit $28.4 million in Q4 2025 for Core Scientific, up from -$1.2 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $86.1 million in Q4 2023 to a low of -$39.0 million in Q3 2021.
  • Historically, Change in Account Payables has averaged $6.1 million across 5 years, with a median of -$396000.0 in 2024.
  • Biggest YoY gain for Change in Account Payables was 4593.67% in 2025; the steepest drop was 674.38% in 2025.
  • Year by year, Change in Account Payables stood at $13.1 million in 2021, then soared by 80.8% to $23.8 million in 2022, then surged by 262.56% to $86.1 million in 2023, then plummeted by 100.73% to -$632000.0 in 2024, then skyrocketed by 4593.67% to $28.4 million in 2025.
  • Business Quant data shows Change in Account Payables for CORZW at $28.4 million in Q4 2025, -$1.2 million in Q3 2025, and -$2.1 million in Q2 2025.